BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

National Institutes of Health (NIH) Awards Grant For Immunetics, Inc.'s New Bacterial Test


10/16/2006 11:51:57 AM

BOSTON--(BUSINESS WIRE)--Immunetics, Inc. (Boston, MA) has received a $2.5 million grant from the National Heart, Lung and Blood Institute to support clinical trials for its BacTx™ test for bacterial contamination of platelet units. The award is a continuation of earlier grants from the NIH that supported the developmental of this test. The NIH grant is intended to help the company obtain FDA approval and bring the product to market. Transfusion of bacterially contaminated platelets can result in severe or fatal sepsis, and remains the highest known risk associated with transfusion of blood products. Screening all platelet units for bacterial contamination has recently been mandated by the American Association of Blood Banks, but rapid tests are not yet available for this purpose. The Immunetics test detects bacteria of all types in a simple and rapid procedure. The clinical trials will be conducted at several major medical centers, following which the Company plans to seek regulatory approval to release the new test.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES